Peripheral vascular surgery using targeted beta blockade reduces perioperative cardiac event rate

Area of Science:

• Cardiology
• Vascular Surgery
• Anesthesiology

Background:

• Current guidelines suggest preoperative cardiac stress testing may be unnecessary for low-to-intermediate cardiac risk patients.
• Targeted beta-blockade therapy has shown potential cardiac protective effects.

Purpose of the Study:

• To evaluate the efficacy of preoperative targeted beta blockade compared to selective cardiac stress testing in preventing cardiac morbidity.
• To assess cardiac outcomes in patients undergoing vascular surgery or major amputation without preoperative cardiac stress testing.

Main Methods:

• A prospective cohort study enrolled 100 patients undergoing vascular surgery or major amputation with low-to-intermediate cardiac risk.
• Targeted beta blockade was initiated preoperatively, and outcomes were compared to 80 historical controls who received selective stress testing and non-targeted beta blockade.
• The primary endpoint was a composite of adverse cardiac outcomes.

Main Results:

• The prospective group (targeted beta blockade) had a significantly lower composite cardiac complication rate (2% vs. 10%, p=0.02) compared to the retrospective group.
• Patients in the prospective group had a significantly lower median heart rate (66 vs. 77 bpm, p=0.0007).
• Multivariate analysis confirmed a lower cardiac complication rate in the prospective group (OR, 2.46; 95% CI, 1.3-4.5; p=0.003).

Conclusions:

• Preoperative targeted beta blockade alone is more effective than selective cardiac stress testing and non-targeted beta blockade for preventing cardiac morbidity in this patient population.
• This approach simplifies preoperative management for low-to-intermediate risk surgical patients.